Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Relmada Therapeutics Inc
RLMDCurrent price
0.30 USD
+0.0017 USD (+0.57%)
Last closed
0.30 USD
Company
www.relmada.com
ISIN
US75955J4022
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
11 731 729 USD
Yield for 12 month
-93.84 %
1Y
3Y
5Y
10Y
15Y
RLMD
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida. Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.87 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures RLMD
1 year
3 years
5 years
10 years
EBITDA
-161 247 824 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-59.13 %
PEG Ratio
–
Return On Equity TTM
-100.41 %
Wall Street Target Price
0.87 USD
Revenue TTM
–
Book Value
2.84 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.86 USD
Diluted Eps TTM
-2.86 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RLMD
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History RLMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:4
Payout Ratio
–
Last Split Date
30.09.2019
Stock Valuation RLMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.54
Price Book MRQ
0.25
Financials RLMD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RLMD
For 52 weeks
0.35 USD
7.22 USD
50 Day MA
2.84 USD
Shares Short Prior Month
1 153 335
200 Day MA
3.48 USD
Short Ratio
4.52
Shares Short
1 059 920
Short Percent
4.23 %
BeatStart